Add listing
    0
    Add listing

    Addex Therapeutics Ltd Verified listing

    • Swiss Biotech Association
      Member

    Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available small molecule drugs known as allosteric modulators for neurological disorders.

    Products, services, technology
    • ADX71149 (mGlu2 PAM)
    • Dipraglurant (mGlu5 NAM)
    • GABAB PAM - SUD
    • GABAB PAM - Chronic cough, pain & CMT1A
    • mGlu7 NAM - Stress-related disorders – PTSD
    • mGlu2 NAM - Mild neurocognitive disorders & depression
    • M4 PAM - Schizophrenia
    • mGlu4 PAM - Parkinson’s
    • mGlu3 PAM - Neurodegenerative disorders
    Location
    Facts & figures
    • Type of organization
      Public company
    • Year of foundation
      2002
    • Number of employees in Switzerland
      20-49
    Key business

    You may also be interested in